Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7320763

Concept	2023-04-01 to 2024-03-31	2023-04-01 to 2024-03-31	2023-04-01 to 2024-03-31	2023-04-01 to 2024-03-31	2022-04-01 to 2023-03-31	2022-04-01 to 2023-03-31	2022-04-01 to 2023-03-31	2022-04-01 to 2023-03-31
Statement of income
Statement of income
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)	—	—	77,149,000 JPY	—	—	87,200,000 JPY	—	—
Taxes and dues	—	—	56,262,000 JPY	—	—	43,374,000 JPY	—	—
Operating expenses
Selling, general and administrative expenses	—	—	—	—	—	—	—	—
Ordinary profit (loss)	—	—	-1,426,891,000 JPY	—	—	-1,325,760,000 JPY	—	—
General and administrative expenses
Salaries	—	—	—	—	—	—	—	—
Operating profit (loss)	—	—	-1,403,464,000 JPY	—	—	-1,315,810,000 JPY	—	—
Non-operating income
Interest income	—	—	14,000 JPY	—	—	13,000 JPY	—	—
Selling, general and administrative expenses
Non-operating income
Non-operating income	—	—	16,000 JPY	—	—	45,000 JPY	—	—
Financial revenue	—	—	—	—	—	—	—	—
Other	—	—	1,000 JPY	—	—	32,000 JPY	—	—
Non-operating expenses
Non-operating expenses	—	—	23,443,000 JPY	—	—	9,995,000 JPY	—	—
Financial expenses	—	—	—	—	—	—	—	—
Share issuance costs	—	—	17,656,000 JPY	—	—	4,207,000 JPY	—	—
Profit (loss) before income taxes	—	—	-1,426,891,000 JPY	—	—	-1,325,760,000 JPY	—	—
Income taxes - current	—	—	2,502,000 JPY	—	—	3,028,000 JPY	—	—
General and administrative expenses
Income taxes	—	—	2,502,000 JPY	—	—	3,028,000 JPY	—	—
Profit (loss)	-1,429,393,000 JPY	-1,429,393,000 JPY	-1,429,393,000 JPY	-1,429,393,000 JPY	-1,328,788,000 JPY	-1,328,788,000 JPY	-1,328,788,000 JPY	-1,328,788,000 JPY